American Society of Clinical Oncology

SHERPA: White

People

  1. Wolden
    Wolden
  2. Lee
    Lee
  3. Yahalom
    Yahalom
  4. Pfister
    Pfister
  5. McBride
    McBride
  6. Wu
    Wu
  7. Riaz
    Riaz
  8. Sherman
    Sherman
  9. Crane
    Crane
  10. Zhang
    Zhang

Groups

  1. Radiation Oncology, Department of (387)
  2. Survivorship Research (236)
  3. Department of Medicine (195)
  4. Solid Tumor Oncology Division (176)
  5. Surgery (136)
  6. Epidemiology and Biostatistics (107)
  7. Biostatistics Service (82)
  8. Center for Hematologic Malignancies (80)
  9. Population Sciences Research Program (79)
  10. GSK Faculty (76)
Search Within
  1. "Radiation Oncology, Department of"
Formats
  1. Meeting Abstract (260)
  2. Journal Article (118)
  3. Guidelines (4)
  4. Review (3)
  5. Correspondence (2)
Groups
  1. Radiation Oncology, Department of (387)
  2. Survivorship Research (236)
  3. Department of Medicine (195)
  4. Solid Tumor Oncology Division (176)
  5. Surgery (136)
  6. Epidemiology and Biostatistics (107)

More Groups

People
  1. Suzanne Wolden (60)
  2. Nancy Lee (52)
  3. Joachim Yahalom (44)
  4. David Pfister (40)
  5. Michael Zelefsky (40)
  6. Sean McBride (38)

More People

Years
  1. 2024 (4)
  2. 2023 (39)
  3. 2022 (30)
  4. 2021 (33)
  5. 2020 (21)
  6. 2019 (30)

More Years

Publications
  1. Journal of Clinical Oncology (374)
  2. JCO Precision Oncology (9)
  3. Journal of Oncology Practice (2)
  4. American Society of Clinical Oncology Educational Book (1)
  5. JCO Clinical Cancer Informatics (1)

Results (387)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized phase III study assessing the efficacy of liquid biopsy in early diagnosis of recurrence and second malignancies in lung cancer survivors
    Meeting Abstract

    Raoof, S.; Gomez, D. R.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Study EV-103 Cohort H: Antitumor activity of neoadjuvant treatment with enfortumab vedotin monotherapy in patients with muscle-invasive bladder cancer who are cisplatin-ineligible
    Meeting Abstract

    Petrylak, D. P.; Flaig, T. W.; Mar, N.; Gourdin, T. S.; Srinivas, S.; Rosenberg, J. E.; Guseva, M.; Yu, Y.; Narayanan, S.; Hoimes, C. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • DASL-HiCaP: Darolutamide augments standard therapy for localized very high-risk cancer of the prostate (ANZUP1801)-A randomized phase 3, double-blind, placebo-controlled trial of adding darolutamide to androgen deprivation therapy and definitive or salvage radiation
    Meeting Abstract

    Niazi, T.; McBride, S. M.; Williams, S.; Davis, I. D.; Stockler, M. R.; Martin, A. J.; Bracken, K.; Roncolato, F.; Horvath, L.; Sengupta, S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Quantification of methylation-specific cardiomyocyte cell-free DNA as an early marker of cardiotoxicity in patients with breast cancer receiving anthracyclines and trastuzumab
    Meeting Abstract

    Moore, Z. R.; Yu, A. F.; Liu, J.; Dang, C. T.; Oeffinger, K. C.; Steingart, R.; Schmitt, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 2 randomized trial of neoadjuvant or palliative chemotherapy with or without immunotherapy for peritoneal mesothelioma (Alliance A092001)
    Meeting Abstract

    Mansfield, A. S.; Goodrich, A.; Foster, N. R.; Ernani, V.; Forde, P. M.; Villaruz, L. C.; Raghav, K. P. S.; Romesser, P. B.; Garbacz, K.; Cao, L.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Molecular profile and clinical outcomes of renal cell carcinoma brain metastases treated with stereotactic radiosurgery
    Meeting Abstract

    Ma, J.; del Balzo, L.; Khaleel, S. S.; Flynn, J.; Zhang, Z.; Voss, M. H.; Freeman, B.; Hakimi, A. A.; Lee, C. H.; Eichholz, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Assessment of telehealth experience among a head and neck oncology population
    Meeting Abstract

    Hung, K. W.; Cracchiolo, J. R.; Kim, S. Y.; Gillespie, E. F.; Pfister, D. G.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Comparison of quality of life in patients randomized to high-dose once daily (QD) thoracic radiotherapy (TRT) with standard twice daily (BID) TRT in limited stage small cell lung cancer (LS-SCLC) on CALGB 30610 (Alliance, Sub-study CALGB 70702)
    Meeting Abstract

    Ganti, A. K.; Dueck, A. C.; Fruth, B.; Rimner, A.; Waqar, S. N.; Mix, M. D.; Petty, W. J.; Bogart, J. A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A pilot study of neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in patients with resectable, locally advanced head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dunn, L.; Sherman, E. J.; Ho, A. L.; Ganly, I.; Riaz, N.; Morris, L.; Hung, K. W.; Kriplani, A.; Cracchiolo, J. R.; Cohen, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save